Poster Abstract Session:
250. Transplants: CMV and Transplantation
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Adult ID

Presentations:
Dasatinib Use May Be a Novel Risk Factor for Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Daniel Prestes, MD ; Esther Arbona, MD ; Alexandra Nevett Fernandez, MD ; Sophia Koo, MD ; Vincent Ho, MD ; John Koreth, MD ; Sarah P. Hammond, MD ; Nicolas Issa, MD ; Lindsey Baden, MD ; Francisco M. Marty, MD, FIDSA
Maribavir Versus Valganciclovir for Preemptive Treatment of Cytomegalovirus (CMV) Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant (SCT) and Solid Organ Transplant (SOT) Recipients
Johan Maertens, MD, PhD ; Catherine Cordonnier, MD ; Peter Jaksch, MD ; Xavier Poiré, MD ; Jingyang J Wu, MS ; Anna Wijatyk, MD ; Faouzi Saliba, MD ; Oliver Witzke, MD ; Stephen Villano, MD
Relevance of graft and donor on CMV transmission in seronegative recipients of solid organ transplantation
Cristina Hernandez, MD ; Carlos Cervera, MD, PhD ; Curtis Mabilangan, BSc ; Jutta Preiksaitis, MD, FRCP (C)
Impact of Viral Load on Eradication of Cytomegalovirus (CMV) Viremia Amongst High-risk Allogeneic Stem Cell Transplant (SCT) Recipients
Jose F. Camargo, MD ; Luis Shimose, MD ; Maria X. Bueno, MD ; Rossana Rosa, MD ; Nikeshan Jeyakumar, MHS ; Michele I Morris, MD, FIDSA ; Lilian M. Abbo, MD ; Jacques Simkins, MD ; Maritza C. Alencar, DNP, ARNP-BC ; Cara Benjamin, PhD ; Mark Goodman, MD ; John J. Byrnes, MD ; Lazaros J. Lekakis, MD ; Denise Pereira, MD ; Krishna V. Komanduri, MD
Establishing Viral Load Cut-off for Early Diagnosis of Cytomegalovirus Infection in Renal Transplant Recipients Using International Standardized Real-time PCR Assay
William Morgan, Medical Student ; Samaa Lutfi, Medical Student ; Rachna Jayaprakash, MD ; Odaliz Abreu Lanfranco, MD ; Anita Patel, MD ; Linoj Samuel, PhD., D(ABMM) ; Ramon Del Busto, MD ; George Alangaden, MD, FIDSA ; Mayur Ramesh, MD
Posters
  • CMV VL Cut-off.pdf (1.1 MB)
  • Cytomegalovirus DNA in Transplant Recipients: Comparison of Whole Blood and Plasma Viral Loads
    Maria Dioverti, M.D. ; Brian Lahr, MS ; Jeffrey Germer, BS ; Joseph Yao, MD, FIDSA ; Raymund R. Razonable, MD, FIDSA
    Posters
  • ID Week poster 2016-10-24.pdf (324.1 kB)
  • Valganciclovir Dosing in Kidney Transplant Recipients for the Prevention of Cytomegalovirus (CMV) Viremia
    Stephanie Shulder, PharmD ; Seema Mehta, MD, MS ; Robin Avery, MD, FIDSA ; Lindsey Pote, PharmD ; Janessa Smith, PharmD ; Nicole Ejaz, PharmD ; Kathryn Dzintars, PharmD
    Utilization of Quantiferon-Cytomegalovirus Assay to Assess the Risk of CMV Disease and Guide Duration of Antiviral Prophylaxis in CMV-Mismatched Solid Organ Transplant Recipients
    Maria Dioverti, M.D. ; Dante Melendez, MD ; Lori Misner, TECHNICAL SPECIALIST II - DLMP ; Elain Beito, SPV-DLMP ; Elitza Theel, PhD ; Raymund R. Razonable, MD, FIDSA
    Posters
  • IDWeekQFTPoster2016estv2.pdf (217.3 kB)
  • Donor CMV Serostatus and Dose Adjustments in CMV Prophylaxis Increase CMV Infection Risk after Lung Transplantation
    Jeffrey B. Doyon, MD, PhD ; Alicia Galar, PharmD, PhD ; Jessica M. Stempel, MD ; Francisco M. Marty, MD, FIDSA ; Hilary J. Goldberg, MD ; Sophia Koo, MD
    Cytomegalovirus (CMV) Resistance Associated Mutations (RAM) after ex vivo T-Cell Depleted (TCD) Hematopoietic Cell Transplant (HCT)
    Seong Jin Kim, MPH ; Julia Foldi, MD., PhD. ; Genovefa Papanicolaou, MD ; Yao-Ting Huang, PhD, MPH
    A Prospective Observational Study to Evaluate a Cytomegalovirus(CMV)–specific T-SPOT® Assay in Hematopoietic Stem Cell Transplant Recipients: The REACT Study Interim Data Review
    Ella Ariza-Heredia, MD ; Dimpy P. Shah, MD, MSPH ; Firas El Chaer, MD ; Kathleen Mullane, DO, FIDSA ; Scott Rowley, MD, FACP ; Pranatharthi Chandrasekar, MD, FIDSA ; Drew J. Winston, MD ; Parameswaran Hari, MD ; Heather Gillis, MS, MBA ; Rajneesh Nath, MD ; Deepali Kumar, MD ; Sherif Mossad, MD, FIDSA ; Per Ljungman, MD, PhD ; Roy F. Chemaly, MD, MPH, FIDSA, FACP
    The ability of CMV–specific ELISPOT assay to predict outcome of low level CMV reactivation in hematopoietic cell transplant recipients
    Dimpy Shah, MD, MSPH, PhD ; Ella Ariza-Heredia, MD ; Firas El Chaer, MD ; Lynn El Haddad, PhD ; Danielle El-Haddad, MD ; Amrita Prayag, M.B.B.S., MS ; Lior Nesher, MD ; Katy Rezvani, MD, PhD ; Elizabeth Shpall, MD ; Roy F. Chemaly, MD, MPH, FIDSA, FACP
    Cytomegalovirus Infection in T Cell Replete Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide- A Single Center Experience
    Zainab Shahid, MD ; Jim Symanowski, Ph.D ; Sarah Lestrange, BS ; Saad Usmani, MD ; Michael Grunwald, MD ; Jonathan Gerber, MD ; Nilanjan Ghosh, MD ; Lewis Mccurdy, MD ; Omotayo Fasan, MD ; Jing Ai, MD ; Belinda Avalos, MD ; Edward Copelan, MD

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.